Argos Therapeutics, Inc.
Industry / private company
Location:
Durham, NC,
United States (USA) (US)
ISNI: 0000000406197158
ROR: https://ror.org/02h9mq080
Show on Map:
Soluble CD83 Inhibits T Cell Activation by Binding to the TLR4/MD-2 Complex on CD14(+) Monocytes (2017)
Horvatinovich JM, Grogan EW, Norris M, Steinkasserer A, Lemos H, Mellor AL, Tcherepanova IY, et al.
Journal article
Soluble CD83 ameliorates experimental colitis in mice (2014)
Eckhardt J, Kreiser S, Döbbeler M, Nicolette C, Debenedette MA, Tcherepanova IY, Ostalecki C, et al.
Journal article
Topical application of soluble CD83 induces IDO-mediated immune modulation, increases Foxp3+ T cells, and prolongs allogeneic corneal graft survival (2013)
Bock F, Roessner S, Onderka J, Lechmann M, Pallotta MT, Fallarino F, Boon L, et al.
Journal article